\-\ Texto\\:\\ \ \(0\)\
\-\ treatment\\ presently\\ consists\\ of\\ surgery\\ \\(either\\ palliative\\ or\\ gastrectomy\\)\\;\\ radiation\\ \\(not\\ normally\\ used\\ due\\ to\\ proximity\\ of\\ other\\ vital\\ organs\\ \\)\\;\\ or\\ chemotherapy\\ using\\ a\\ triple\\ regimen\\ of\\ 5\\-fu\\,\\ mitomycin\\ c\\ and\\ doxorubicin\\ with\\ up\\ to\\ a\\ 30\\%\\ response\\ in\\ early\\ diagnosed\\ gastric\\ ca\\.\ \(0\)\
\-\ an\\ abdominal\\ ct\\ with\\ contrast\\ was\\ obtained\\.\\ \\ a\\.\\ although\\ this\\ is\\ an\\ abdominal\\ ct\\ with\\ contrast\\,\\ note\\ the\\ sequestration\\ of\\ contrast\\ material\\ in\\ the\\ stomach\\ secondary\\ to\\ complete\\ gastric\\ outlet\\ obstruction\\.\\ there\\ is\\ a\\ 2\\ cm\\ mass\\ posterior\\ to\\ the\\ stomach\\ in\\ the\\ vicinity\\ of\\ the\\ antrum\\.\\ there\\ is\\ a\\ cleavage\\ plane\\ between\\ the\\ mass\\ and\\ the\\ head\\ of\\ the\\ pancreas\\ which\\ suggests\\ a\\ gastric\\ etiology\\.\\ there\\ is\\ a\\ large\\ infarct\\ in\\ the\\ right\\ lobe\\ of\\ the\\ liver\\,\\ most\\ likely\\ secondary\\ to\\ right\\ portal\\ vein\\ thrombosis\\.\\ \\ b\\.\\ 2cm\\ gastric\\ mass\\ can\\ be\\ seen\\.\\ omental\\ caking\\ is\\ indicative\\ of\\ carcinomatosis\\ is\\ seen\\ anterior\\ to\\ the\\ liver\\.\\ significant\\ ascites\\ is\\ noted\\ throughout\\ the\\ abdomen\\.\\ there\\ are\\ multiple\\ hypodensities\\ in\\ both\\ kidneys\\ which\\ appear\\ consistent\\ with\\ a\\ cystic\\ etiology\\.\\ adenopathy\\ is\\ present\\ in\\ the\\ periaortic\\ and\\ parapancreatic\\ regions\\.\\ \\ c\\.\\ more\\ evidence\\ of\\ omental\\ caking\\,\\ ascites\\,\\ renal\\ cysts\\ and\\ marked\\ adenopathy\\.\ \(0\)\
\-\ adenocarcinoma\\ of\\ gastric\\ antrum\ \(0\)\
\-\ 54yo\\ caucasian\\ male\\ with\\ 3\\ month\\ history\\ of\\ progressive\\ early\\ satiety\\,\\ post\\ prandial\\ vomiting\\ and\\ anorexia\\.\\ patient\\ reported\\ weight\\ loss\\ in\\ excess\\ of\\ 15\\ pounds\\ during\\ previous\\ 1\\ month\\.\\ patient\\ has\\ an\\ 80\\ pack\\ year\\ history\\ of\\ smoking\\ and\\ 25\\ year\\ history\\ of\\ heavy\\ alcohol\\ ingestion\\.\ \(0\)\
\-\ stomach\\ cancer\\ is\\ the\\ most\\ common\\ internal\\ malignancy\\ worldwide\\.\\ adenocarcinoma\\ is\\ the\\ responsible\\ etiology\\ for\\ over\\ 90\\%\\ of\\ gastric\\ neoplasms\\.\\ over\\ half\\ of\\ gastric\\ adenocarcinomas\\ are\\ located\\ in\\ the\\ antrum\\,\\ the\\ rest\\ are\\ distributed\\ in\\ the\\ body\\,\\ cardia\\,\\ and\\ fundus\\ in\\ descending\\ order\\.\\ patients\\ typically\\ present\\ with\\ weight\\ loss\\,\\ anorexia\\,\\ dyspepsia\\,\\ early\\ satiety\\,\\ anemia\\ \\(iron\\ deficiency\\)\\,\\ hematemesis\\.\\ a\\ left\\ supraclavicular\\ \\(virchow\\'s\\ node\\)\\ lymph\\ node\\ may\\ be\\ palpable\\ late\\ in\\ the\\ disease\\.\\ lymph\\ node\\ metastases\\ are\\ present\\ in\\ greater\\ than\\ 50\\%\\ of\\ patients\\ at\\ time\\ of\\ diagnosis\\.\\ although\\ the\\ exact\\ etiology\\ remains\\ unknown\\,\\ risk\\ factors\\ for\\ this\\ disease\\ appear\\ to\\ be\\:\\ male\\ sex\\,\\ race\\ \\(japan\\ has\\ 5\\-10\\ times\\ the\\ incidence\\ as\\ the\\ usa\\ believed\\ due\\ to\\ polycyclic\\ hydrocarbon\\ ingestion\\ in\\ smoked\\ fish\\)\\,\\ chile\\ also\\ has\\ a\\ much\\ higher\\ incidence\\,\\ age\\ \\(50\\ plus\\)\\,\\ precancerous\\ lesions\\ \\(such\\ as\\ pernicious\\ anemia\\ \\(atrophic\\ gastritis\\ type\\ a\\)\\,\\ adenomatous\\ polyp\\,\\ chronic\\ h\\.\\ pylori\\ gastritis\\)\\,\\ status\\ post\\ subtotal\\ gastrectomy\\.\\ dietary\\ risk\\ factors\\ may\\ be\\ the\\ most\\ significant\\.\\ ingestion\\ of\\ increased\\ salt\\ and\\ smoked\\ foods\\,\\ vitamin\\ c\\ deficiency\\,\\ poor\\ carbohydrate\\ intake\\,\\ and\\ increased\\ nitrate\\ consumption\\ are\\ apparent\\ risk\\ factors\\ for\\ this\\ cancer\\.\\ there\\ has\\ been\\ a\\ definitive\\ correlation\\ between\\ well\\ water\\ nitrate\\ content\\ and\\ gastric\\ ca\ \(0\)\
\-\ \\ \\ \\ \\ \\ the\\ prognosis\\ for\\ gastric\\ ca\\ is\\ remains\\ poor\\ in\\ the\\ long\\ term\\.\\ early\\ diagnosis\\ where\\ the\\ cancer\\ is\\ restricted\\ to\\ the\\ gastric\\ mucosa\\ and\\ submucosa\\ has\\ a\\ 85\\%\\ five\\ year\\ survival\\.\\ tumors\\ that\\ have\\ invaded\\ the\\ muscle\\ wall\\,\\ but\\ not\\ the\\ lymph\\ nodes\\ have\\ a\\ 30\\%\\ five\\ year\\ survival\\,\\ and\\ tumors\\ that\\ have\\ extended\\ through\\ the\\ full\\ thickness\\ of\\ the\\ wall\\ and\\ involves\\ lymph\\ nodes\\ has\\ a\\ very\\ poor\\ 5\\%\\ five\\ year\\ survival\\ rate\\.\\ most\\ cancers\\ are\\ diagnosed\\ in\\ late\\ stage\\ which\\ is\\ when\\ symptoms\\ present\\.\\ gastric\\ ca\\ is\\ spread\\ by\\ several\\ means\\,\\ including\\:\\ 1\\)\\ direct\\ extension\\ to\\ the\\ liver\\,\\ greater\\ omentum\\,\\ pancreas\\,\\ spleen\\;\\ 2\\)\\ lymphatic\\:\\ local\\ nodes\\,\\ regional\\ nodes\\,\\ distant\\ nodes\\;\\ 3\\)\\ hematogenous\\:\\ hepatic\\,\\ pulmonary\\,\\ bone\\,\\ cns\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ in\\ the\\ case\\ of\\ this\\ patient\\ who\\ presented\\ very\\ late\\ in\\ his\\ illness\\ he\\ died\\ less\\ than\\ 5\\ weeks\\ after\\ his\\ initial\\ presentation\\.\\ this\\ patient\\ demonstrated\\ a\\ classic\\ presentation\\ for\\ this\\ illness\\-\\ post\\ prandial\\ vomiting\\ \\(approx\\ 30\\ mins\\ after\\ meal\\)\\,\\ significant\\ weight\\ loss\\,\\ liquid\\ diet\\ for\\ 2\\ months\\ \\(unable\\ to\\ pass\\ solids\\ thru\\ antrum\\)\\ which\\ ultimately\\ progressed\\ to\\ an\\ inability\\ to\\ tolerate\\ liquids\\ for\\ 2\\ weeks\\ prior\\ to\\ admission\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gastric\\:\\ 0\\.3358746158776394\ \(0\)\
\-\ the\\:\\ 0\\.2386883308490611\ \(0\)\
\-\ antrum\\:\\ 0\\.16140509801651262\ \(0\)\
\-\ nodes\\:\\ 0\\.15396731728769175\ \(0\)\
\-\ in\\:\\ 0\\.15329857510154188\ \(0\)\
\-\ of\\:\\ 0\\.14896895547372704\ \(0\)\
\-\ is\\:\\ 0\\.13897831127078675\ \(0\)\
\-\ to\\:\\ 0\\.12687034093305538\ \(0\)\
\-\ ca\\:\\ 0\\.12370899785247753\ \(0\)\
\-\ ingestion\\:\\ 0\\.11777770430296074\ \(0\)\
\-\ etiology\\:\\ 0\\.11680546315286748\ \(0\)\
\-\ lymph\\:\\ 0\\.11275017241744789\ \(0\)\
\-\ survival\\:\\ 0\\.10613145473893566\ \(0\)\
\-\ early\\:\\ 0\\.1045175301476789\ \(0\)\
\-\ caking\\:\\ 0\\.10429461345401717\ \(0\)\
\-\ late\\:\\ 0\\.10265571274595381\ \(0\)\
\-\ gastrectomy\\:\\ 0\\.10197745212536259\ \(0\)\
\-\ nitrate\\:\\ 0\\.10197745212536259\ \(0\)\
\-\ has\\:\\ 0\\.09934479493769359\ \(0\)\
\-\ five\\:\\ 0\\.09822104745246263\ \(0\)\
\-\ and\\:\\ 0\\.09737523221608178\ \(0\)\
\-\ prandial\\:\\ 0\\.09548526655010399\ \(0\)\
\-\ smoked\\:\\ 0\\.09427395030888036\ \(0\)\
\-\ node\\:\\ 0\\.09347004703598077\ \(0\)\
\-\ factors\\:\\ 0\\.091987308371473\ \(0\)\
\-\ poor\\:\\ 0\\.0917296855098921\ \(0\)\
\-\ gastritis\\:\\ 0\\.09120897323309543\ \(0\)\
\-\ stomach\\:\\ 0\\.0907326582275294\ \(0\)\
\-\ satiety\\:\\ 0\\.09033212895547077\ \(0\)\
\-\ anorexia\\:\\ 0\\.08667591964619083\ \(0\)\
\-\ omental\\:\\ 0\\.08435875831753625\ \(0\)\
\-\ are\\:\\ 0\\.08252897591310303\ \(0\)\
\-\ risk\\:\\ 0\\.07770165177293621\ \(0\)\
\-\ for\\:\\ 0\\.07690745757258634\ \(0\)\
\-\ weight\\:\\ 0\\.07583459003307225\ \(0\)\
\-\ most\\:\\ 0\\.07546021260616075\ \(0\)\
\-\ liver\\:\\ 0\\.07501861091551437\ \(0\)\
\-\ ascites\\:\\ 0\\.07477892090384695\ \(0\)\
\-\ this\\:\\ 0\\.0747347595929891\ \(0\)\
\-\ present\\:\\ 0\\.07440206180828424\ \(0\)\
\-\ 30\\:\\ 0\\.07418508791930759\ \(0\)\
\-\ illness\\:\\ 0\\.0729270401941001\ \(0\)\
\-\ cancer\\:\\ 0\\.07243309857850183\ \(0\)\
\-\ there\\:\\ 0\\.07211673080561533\ \(0\)\
\-\ deficiency\\:\\ 0\\.07093717251702551\ \(0\)\
\-\ remains\\:\\ 0\\.06905722583836449\ \(0\)\
\-\ pancreas\\:\\ 0\\.0681380880072609\ \(0\)\
\-\ anemia\\:\\ 0\\.06660836176540422\ \(0\)\
\-\ loss\\:\\ 0\\.06625257321423457\ \(0\)\
\-\ which\\:\\ 0\\.06593103954531061\ \(0\)\
\-\ significant\\:\\ 0\\.06278804192527329\ \(0\)\
\-\ incidence\\:\\ 0\\.062407159958378\ \(0\)\
\-\ adenopathy\\:\\ 0\\.060983665148178365\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.05925506436894513\ \(0\)\
\-\ post\\:\\ 0\\.05917263775718692\ \(0\)\
\-\ be\\:\\ 0\\.058819005371620645\ \(0\)\
\-\ parapancreatic\\:\\ 0\\.05796996831195449\ \(0\)\
\-\ polycyclic\\:\\ 0\\.05796996831195449\ \(0\)\
\-\ hydrocarbon\\:\\ 0\\.05796996831195449\ \(0\)\
\-\ chile\\:\\ 0\\.05796996831195449\ \(0\)\
\-\ precancerous\\:\\ 0\\.05796996831195449\ \(0\)\
\-\ appear\\:\\ 0\\.057098079289581063\ \(0\)\
\-\ year\\:\\ 0\\.05585606917528977\ \(0\)\
\-\ an\\:\\ 0\\.05544591279603406\ \(0\)\
\-\ 54yo\\:\\ 0\\.05539339951463788\ \(0\)\
\-\ carbohydrate\\:\\ 0\\.05539339951463788\ \(0\)\
\-\ mins\\:\\ 0\\.05539339951463788\ \(0\)\
\-\ have\\:\\ 0\\.05432502198588541\ \(0\)\
\-\ vomiting\\:\\ 0\\.05364497155418229\ \(0\)\
\-\ dyspepsia\\:\\ 0\\.0535652948599979\ \(0\)\
\-\ pernicious\\:\\ 0\\.0535652948599979\ \(0\)\
\-\ greater\\:\\ 0\\.05341090967000433\ \(0\)\
\-\ tumors\\:\\ 0\\.05331847870919918\ \(0\)\
\-\ contrast\\:\\ 0\\.05283787940922523\ \(0\)\
\-\ diagnosed\\:\\ 0\\.05251552534373549\ \(0\)\
\-\ mitomycin\\:\\ 0\\.05214730672700858\ \(0\)\
\-\ vicinity\\:\\ 0\\.05214730672700858\ \(0\)\
\-\ cleavage\\:\\ 0\\.05214730672700858\ \(0\)\
\-\ very\\:\\ 0\\.052007089501387396\ \(0\)\
\-\ adenocarcinomas\\:\\ 0\\.050988726062681296\ \(0\)\
\-\ fish\\:\\ 0\\.050988726062681296\ \(0\)\
\-\ thru\\:\\ 0\\.050988726062681296\ \(0\)\
\-\ 50\\:\\ 0\\.05063071638059569\ \(0\)\
\-\ presentation\\:\\ 0\\.04990634935061853\ \(0\)\
\-\ although\\:\\ 0\\.049355186515002515\ \(0\)\
\-\ japan\\:\\ 0\\.049160621408041325\ \(0\)\
\-\ submucosa\\:\\ 0\\.049160621408041325\ \(0\)\
\-\ invaded\\:\\ 0\\.049160621408041325\ \(0\)\
\-\ periaortic\\:\\ 0\\.04841215726536468\ \(0\)\
\-\ worldwide\\:\\ 0\\.04841215726536468\ \(0\)\
\-\ cardia\\:\\ 0\\.04841215726536468\ \(0\)\
\-\ presently\\:\\ 0\\.047742633275051995\ \(0\)\
\-\ salt\\:\\ 0\\.047742633275051995\ \(0\)\
\-\ consumption\\:\\ 0\\.047742633275051995\ \(0\)\
\-\ omentum\\:\\ 0\\.047742633275051995\ \(0\)\
\-\ patient\\:\\ 0\\.047159859539183335\ \(0\)\
\-\ hematemesis\\:\\ 0\\.04713697515444018\ \(0\)\
\-\ virchow\\:\\ 0\\.04713697515444018\ \(0\)\
\-\ between\\:\\ 0\\.04710562747920623\ \(0\)\
\-\ hypodensities\\:\\ 0\\.04658405261072471\ \(0\)\
\-\ race\\:\\ 0\\.0460754131768493\ \(0\)\
\-\ subtotal\\:\\ 0\\.045604486616547715\ \(0\)\
\-\ foods\\:\\ 0\\.045604486616547715\ \(0\)\
\-\ doxorubicin\\:\\ 0\\.045166064477735385\ \(0\)\
\-\ meal\\:\\ 0\\.045166064477735385\ \(0\)\
\-\ liquids\\:\\ 0\\.045166064477735385\ \(0\)\
\-\ pylori\\:\\ 0\\.044755947956084736\ \(0\)\
\-\ distributed\\:\\ 0\\.044370702701196675\ \(0\)\
\-\ plus\\:\\ 0\\.044370702701196675\ \(0\)\
\-\ month\\:\\ 0\\.044101314962955794\ \(0\)\
\-\ wall\\:\\ 0\\.044101314962955794\ \(0\)\
\-\ his\\:\\ 0\\.043968233107250364\ \(0\)\
\-\ sex\\:\\ 0\\.043663908219610165\ \(0\)\
\-\ usa\\:\\ 0\\.043663908219610165\ \(0\)\
\-\ liquid\\:\\ 0\\.043663908219610165\ \(0\)\
\-\ solids\\:\\ 0\\.043663908219610165\ \(0\)\
\-\ weeks\\:\\ 0\\.043449418169926285\ \(0\)\
\-\ tolerate\\:\\ 0\\.043337959823095414\ \(0\)\
\-\ proximity\\:\\ 0\\.043027917819231105\ \(0\)\
\-\ secondary\\:\\ 0\\.04297133788635777\ \(0\)\
\-\ atrophic\\:\\ 0\\.04273230170248359\ \(0\)\
\-\ with\\:\\ 0\\.04258798982546436\ \(0\)\
\-\ triple\\:\\ 0\\.042449828507785954\ \(0\)\
\-\ excess\\:\\ 0\\.042449828507785954\ \(0\)\
\-\ dietary\\:\\ 0\\.042449828507785954\ \(0\)\
\-\ adenomatous\\:\\ 0\\.04191997169010609\ \(0\)\
\-\ due\\:\\ 0\\.04167315553930737\ \(0\)\
\-\ history\\:\\ 0\\.04154759632152852\ \(0\)\
\-\ mass\\:\\ 0\\.041538397864588836\ \(0\)\
\-\ responsible\\:\\ 0\\.041430915016091495\ \(0\)\
\-\ lymphatic\\:\\ 0\\.041430915016091495\ \(0\)\
\-\ approx\\:\\ 0\\.041430915016091495\ \(0\)\
\-\ heavy\\:\\ 0\\.041199813164591134\ \(0\)\
\-\ hematogenous\\:\\ 0\\.041199813164591134\ \(0\)\
\-\ than\\:\\ 0\\.04109700244670536\ \(0\)\
\-\ outlet\\:\\ 0\\.04097682184456303\ \(0\)\
\-\ patients\\:\\ 0\\.04078403776860741\ \(0\)\
\-\ means\\:\\ 0\\.040553024799768744\ \(0\)\
\-\ regional\\:\\ 0\\.040351274504128155\ \(0\)\
\-\ over\\:\\ 0\\.04031202379797042\ \(0\)\
\-\ regimen\\:\\ 0\\.04015573290516698\ \(0\)\
\-\ pounds\\:\\ 0\\.039966029249240094\ \(0\)\
\-\ iron\\:\\ 0\\.039966029249240094\ \(0\)\
\-\ exact\\:\\ 0\\.039781825031601804\ \(0\)\
\-\ abdominal\\:\\ 0\\.039651028621030204\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.03960281036145152\ \(0\)\
\-\ intake\\:\\ 0\\.03960281036145152\ \(0\)\
\-\ diet\\:\\ 0\\.039428700825119366\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.039259234767653584\ \(0\)\
\-\ increased\\:\\ 0\\.03920342093661269\ \(0\)\
\-\ palliative\\:\\ 0\\.039094170927576104\ \(0\)\
\-\ cancers\\:\\ 0\\.038933286371138826\ \(0\)\
\-\ believed\\:\\ 0\\.038776374681693024\ \(0\)\
\-\ sequestration\\:\\ 0\\.03818482222846219\ \(0\)\
\-\ vitamin\\:\\ 0\\.03804515505582937\ \(0\)\
\-\ died\\:\\ 0\\.03804515505582937\ \(0\)\
\-\ distant\\:\\ 0\\.03790849171239258\ \(0\)\
\-\ ultimately\\:\\ 0\\.03790849171239258\ \(0\)\
\-\ 2cm\\:\\ 0\\.037643678373097525\ \(0\)\
\-\ pack\\:\\ 0\\.037643678373097525\ \(0\)\
\-\ fundus\\:\\ 0\\.037643678373097525\ \(0\)\
\-\ progressed\\:\\ 0\\.037643678373097525\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0375824012998403\ \(0\)\
\-\ organs\\:\\ 0\\.03738946045192348\ \(0\)\
\-\ extended\\:\\ 0\\.03738946045192348\ \(0\)\
\-\ pass\\:\\ 0\\.03738946045192348\ \(0\)\
\-\ inability\\:\\ 0\\.03738946045192348\ \(0\)\
\-\ indicative\\:\\ 0\\.03726606627293613\ \(0\)\
\-\ polyp\\:\\ 0\\.03690964011753768\ \(0\)\
\-\ plane\\:\\ 0\\.036572148392606446\ \(0\)\
\-\ may\\:\\ 0\\.03648323296648557\ \(0\)\
\-\ water\\:\\ 0\\.03625168046262016\ \(0\)\
\-\ correlation\\:\\ 0\\.03614835134781216\ \(0\)\
\-\ consists\\:\\ 0\\.03604667556995791\ \(0\)\
\-\ content\\:\\ 0\\.03584807813994681\ \(0\)\
\-\ spleen\\:\\ 0\\.03528701389038233\ \(0\)\
\-\ after\\:\\ 0\\.03516992328704583\ \(0\)\
\-\ mucosa\\:\\ 0\\.03493872944083289\ \(0\)\
\-\ portal\\:\\ 0\\.03468949747561952\ \(0\)\
\-\ half\\:\\ 0\\.03414336766429418\ \(0\)\
\-\ seen\\:\\ 0\\.03413142775867712\ \(0\)\
\-\ cns\\:\\ 0\\.03385115063858565\ \(0\)\
\-\ neoplasms\\:\\ 0\\.03378014877650561\ \(0\)\
\-\ thickness\\:\\ 0\\.033640481603872785\ \(0\)\
\-\ smoking\\:\\ 0\\.03357178255049555\ \(0\)\
\-\ alcohol\\:\\ 0\\.03350381826043599\ \(0\)\
\-\ order\\:\\ 0\\.03350381826043599\ \(0\)\
\-\ response\\:\\ 0\\.03343657318270767\ \(0\)\
\-\ suggests\\:\\ 0\\.03343657318270767\ \(0\)\
\-\ 85\\:\\ 0\\.03343657318270767\ \(0\)\
\-\ definitive\\:\\ 0\\.03311062478619292\ \(0\)\
\-\ normally\\:\\ 0\\.03304739440832176\ \(0\)\
\-\ higher\\:\\ 0\\.03292279040533345\ \(0\)\
\-\ descending\\:\\ 0\\.03274034915082088\ \(0\)\
\-\ times\\:\\ 0\\.032621568112178326\ \(0\)\
\-\ spread\\:\\ 0\\.03256299995061745\ \(0\)\
\-\ male\\:\\ 0\\.03227885720315957\ \(0\)\
\-\ vital\\:\\ 0\\.03227799251838039\ \(0\)\
\-\ caucasian\\:\\ 0\\.03222249347088346\ \(0\)\
\-\ direct\\:\\ 0\\.031952044121865635\ \(0\)\
\-\ prognosis\\:\\ 0\\.03189930854496928\ \(0\)\
\-\ involves\\:\\ 0\\.03154192760021499\ \(0\)\
\-\ that\\:\\ 0\\.03146137298675159\ \(0\)\
\-\ much\\:\\ 0\\.03139471019265827\ \(0\)\
\-\ unable\\:\\ 0\\.03139471019265827\ \(0\)\
\-\ rest\\:\\ 0\\.03134638600125381\ \(0\)\
\-\ kidneys\\:\\ 0\\.031203579979189\ \(0\)\
\-\ local\\:\\ 0\\.031203579979189\ \(0\)\
\-\ restricted\\:\\ 0\\.031156682345326925\ \(0\)\
\-\ regions\\:\\ 0\\.03111012828695875\ \(0\)\
\-\ material\\:\\ 0\\.030534055988876308\ \(0\)\
\-\ disease\\:\\ 0\\.03043204597935616\ \(0\)\
\-\ apparent\\:\\ 0\\.030325689762866252\ \(0\)\
\-\ admission\\:\\ 0\\.03024421940917647\ \(0\)\
\-\ infarct\\:\\ 0\\.030163780353504265\ \(0\)\
\-\ either\\:\\ 0\\.029967027777779855\ \(0\)\
\-\ using\\:\\ 0\\.02981389746336135\ \(0\)\
\-\ thrombosis\\:\\ 0\\.029554489994699316\ \(0\)\
\-\ metastases\\:\\ 0\\.029305258029485942\ \(0\)\
\-\ as\\:\\ 0\\.029124982343363654\ \(0\)\
\-\ 90\\:\\ 0\\.028965358802898373\ \(0\)\
\-\ stage\\:\\ 0\\.02886683589067361\ \(0\)\
\-\ hepatic\\:\\ 0\\.02886683589067361\ \(0\)\
\-\ located\\:\\ 0\\.02867425750022772\ \(0\)\
\-\ not\\:\\ 0\\.028620449260349057\ \(0\)\
\-\ where\\:\\ 0\\.02848734400923957\ \(0\)\
\-\ term\\:\\ 0\\.028426241610139267\ \(0\)\
\-\ full\\:\\ 0\\.028335675698864297\ \(0\)\
\-\ 80\\:\\ 0\\.028276007649711606\ \(0\)\
\-\ progressive\\:\\ 0\\.02776280148869328\ \(0\)\
\-\ ct\\:\\ 0\\.027600633980293776\ \(0\)\
\-\ cysts\\:\\ 0\\.027468430517545106\ \(0\)\
\-\ unknown\\:\\ 0\\.027468430517545106\ \(0\)\
\-\ rate\\:\\ 0\\.027468430517545106\ \(0\)\
\-\ marked\\:\\ 0\\.027416343336195033\ \(0\)\
\-\ previous\\:\\ 0\\.027390458980463245\ \(0\)\
\-\ note\\:\\ 0\\.02728796320124701\ \(0\)\
\-\ used\\:\\ 0\\.027137254148258405\ \(0\)\
\-\ malignancy\\:\\ 0\\.027137254148258405\ \(0\)\
\-\ classic\\:\\ 0\\.027112479845744903\ \(0\)\
\-\ throughout\\:\\ 0\\.02665923935459959\ \(0\)\
\-\ reported\\:\\ 0\\.026108235760180263\ \(0\)\
\-\ vein\\:\\ 0\\.025982811940961706\ \(0\)\
\-\ including\\:\\ 0\\.025941548156060253\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.025739155235092136\ \(0\)\
\-\ muscle\\:\\ 0\\.025739155235092136\ \(0\)\
\-\ 25\\:\\ 0\\.025679673360422598\ \(0\)\
\-\ extension\\:\\ 0\\.025659969156895772\ \(0\)\
\-\ obtained\\:\\ 0\\.025640325862905128\ \(0\)\
\-\ palpable\\:\\ 0\\.025466216326572977\ \(0\)\
\-\ typically\\:\\ 0\\.02544716203779616\ \(0\)\
\-\ complete\\:\\ 0\\.02540922401140477\ \(0\)\
\-\ obstruction\\:\\ 0\\.02539033959766762\ \(0\)\
\-\ status\\:\\ 0\\.025296750269107195\ \(0\)\
\-\ or\\:\\ 0\\.025220731026669375\ \(0\)\
\-\ less\\:\\ 0\\.024660759868728132\ \(0\)\
\-\ 15\\:\\ 0\\.024494833978788943\ \(0\)\
\-\ internal\\:\\ 0\\.024429658017227775\ \(0\)\
\-\ type\\:\\ 0\\.024317184274930202\ \(0\)\
\-\ initial\\:\\ 0\\.024317184274930202\ \(0\)\
\-\ long\\:\\ 0\\.02403678876556932\ \(0\)\
\-\ right\\:\\ 0\\.024036055933779277\ \(0\)\
\-\ radiation\\:\\ 0\\.024021568158182686\ \(0\)\
\-\ body\\:\\ 0\\.02385650431810521\ \(0\)\
\-\ several\\:\\ 0\\.02378286965240539\ \(0\)\
\-\ such\\:\\ 0\\.02331717450801289\ \(0\)\
\-\ during\\:\\ 0\\.02296000618059181\ \(0\)\
\-\ age\\:\\ 0\\.0227574519630644\ \(0\)\
\-\ renal\\:\\ 0\\.02257324774542612\ \(0\)\
\-\ demonstrated\\:\\ 0\\.02227763162867861\ \(0\)\
\-\ abdomen\\:\\ 0\\.022117902559206214\ \(0\)\
\-\ pulmonary\\:\\ 0\\.022095408374493537\ \(0\)\
\-\ when\\:\\ 0\\.02189646550127364\ \(0\)\
\-\ cystic\\:\\ 0\\.02183151160819097\ \(0\)\
\-\ likely\\:\\ 0\\.021661478707091984\ \(0\)\
\-\ head\\:\\ 0\\.02161967197376108\ \(0\)\
\-\ through\\:\\ 0\\.021578138489005125\ \(0\)\
\-\ chronic\\:\\ 0\\.021516342858953083\ \(0\)\
\-\ time\\:\\ 0\\.021485668943178885\ \(0\)\
\-\ he\\:\\ 0\\.021465301616301103\ \(0\)\
\-\ presented\\:\\ 0\\.021138336565029222\ \(0\)\
\-\ been\\:\\ 0\\.02111905096435132\ \(0\)\
\-\ months\\:\\ 0\\.021099823716563437\ \(0\)\
\-\ lobe\\:\\ 0\\.020948064849338317\ \(0\)\
\-\ cm\\:\\ 0\\.020818185280559395\ \(0\)\
\-\ lesions\\:\\ 0\\.020818185280559395\ \(0\)\
\-\ evidence\\:\\ 0\\.020574960389459766\ \(0\)\
\-\ common\\:\\ 0\\.020557308709926676\ \(0\)\
\-\ who\\:\\ 0\\.020504645973059277\ \(0\)\
\-\ prior\\:\\ 0\\.020281353251435277\ \(0\)\
\-\ anterior\\:\\ 0\\.02023929750199679\ \(0\)\
\-\ both\\:\\ 0\\.020214197006375757\ \(0\)\
\-\ more\\:\\ 0\\.01990455264967818\ \(0\)\
\-\ symptoms\\:\\ 0\\.01983337405245201\ \(0\)\
\-\ bone\\:\\ 0\\.019778558920421047\ \(0\)\
\-\ consistent\\:\\ 0\\.019655014799820313\ \(0\)\
\-\ surgery\\:\\ 0\\.019488970659454593\ \(0\)\
\-\ noted\\:\\ 0\\.01921914214972658\ \(0\)\
\-\ can\\:\\ 0\\.019022302501420507\ \(0\)\
\-\ other\\:\\ 0\\.018824663605319644\ \(0\)\
\-\ posterior\\:\\ 0\\.018744646591551978\ \(0\)\
\-\ case\\:\\ 0\\.01821108014122393\ \(0\)\
\-\ large\\:\\ 0\\.018162525173026193\ \(0\)\
\-\ up\\:\\ 0\\.01793099146175837\ \(0\)\
\-\ but\\:\\ 0\\.01792516422563625\ \(0\)\
\-\ multiple\\:\\ 0\\.01773015215465721\ \(0\)\
\-\ well\\:\\ 0\\.017551922051523887\ \(0\)\
\-\ treatment\\:\\ 0\\.017267300056110203\ \(0\)\
\-\ also\\:\\ 0\\.017050468928694072\ \(0\)\
\-\ by\\:\\ 0\\.015393408066141822\ \(0\)\
\-\ at\\:\\ 0\\.013691688694590491\ \(0\)\
\-\ was\\:\\ 0\\.012633119229673646\ \(0\)\
\-\ left\\:\\ 0\\.012365308680990183\ \(0\)\
